Tag: Lyora Therapeutics
Five Questions With: Pam Stetkiewicz
After operating in stealth for its first year, Lyora Therapeutics publicly launched in July, announcing Pam Stetkiewicz as the Providence-based biotech company’s CEO.
With $2.5 million in pre-seed funding, Lyora develops medications for those living with inherited...
Providence retinal disease treatment firm publicly launches
PROVIDENCE – Lyora Therapeutics, a Providence-based biotech company specializing in the treatment of hereditary retinal diseases, has officially launched publicly after operating in stealth for the past year.
Lyora’s portfolio...
R.I. Life Science Hub grants $4.5M to 8 companies
PROVIDENCE – The R.I. Life Science Hub has awarded $4.5 million to help seven companies either relocate or launch their businesses in the state.
An...
- Featured Event -
